APPLICATION
ANDA075453
TYPE
ANDA
ORIGINAL APPROVAL
2000-10-18
LATEST ACTION
2005-11-29
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
DOXAZOSIN MESYLATEDiscontinued
DOXAZOSIN MESYLATE EQ 4MG BASE · TABLET · ORAL
DOXAZOSIN MESYLATEDiscontinued
DOXAZOSIN MESYLATE EQ 1MG BASE · TABLET · ORAL
DOXAZOSIN MESYLATEDiscontinued
DOXAZOSIN MESYLATE EQ 8MG BASE · TABLET · ORAL
DOXAZOSIN MESYLATEDiscontinued
DOXAZOSIN MESYLATE EQ 2MG BASE · TABLET · ORAL
Approval history
2005-11-29Labeling · Supplement 17AP
2002-12-11Manufacturing (CMC) · Supplement 6AP
2002-12-11Manufacturing (CMC) · Supplement 4AP
2002-12-11Labeling · Supplement 5AP
2002-12-11Manufacturing (CMC) · Supplement 3AP
2002-08-28Labeling · Supplement 2AP
2002-08-28Manufacturing (CMC) · Supplement 1AP
2002-07-29Manufacturing (CMC) · Supplement 9AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.